DND<i>i</i>によるNTDs治療薬開発のための国際パートナーシップ

DOI Web Site Web Site PubMed 参考文献2件

書誌事項

タイトル別名
  • International Partnership for Therapeutic Drug Development of NTDs by DND<i>i</i>
  • Symposium Review : DNDiによるNTDs治療薬開発のための国際パートナーシップ
  • Symposium Review : DNDi ニ ヨル NTDs チリョウヤク カイハツ ノ タメ ノ コクサイ パートナーシップ

この論文をさがす

抄録

  The Drugs for Neglected Diseases initiative (DNDi), with headquarters in Geneva, is a non-profit drug research and development (R&D) organization and Product Development Partnership (PDP) which was established in 2003 by 7 founding organizations such as Médecins Sans Frontières (MSF), the Pasteur Institute, The Specific Programme for Research and Training in Tropical Diseases (WHO-TDR), etc. DNDi has worked mainly on the development of new treatments for neglected tropical diseases (NTDs), which is difficult to achieve under market economy conditions. DNDi has promoted overall drug discovery research including the screening of drug candidates, hit to lead, lead optimization, pre-clinical and clinical studies in the area of infectious diseases with a focus on malaria, sleeping sickness (human African trypanosomiasis; HAT), Chagas disease, leishmaniasis, filarial diseases and pediatric formulations for HIV treatment. DNDi's achievements include the development of novel therapies based on patient needs through innovative partnerships with over 130 organizations in industry, government, academia, and public institutions around the world. To date, DNDi has registered 6 novel treatments adapted to the needs of patients in poor countries, and has another 12 novel entities in development. DNDi Japan is a Japanese non-profit organization (NPO) based on the global principles of DNDi and, as the only PDP in Japan, is supporting NTD drug discovery projects in collaboration with Japanese pharmaceutical companies, academic institutions and government agencies by utilizing Japan's excellent R&D capabilities to develop new treatments for NTDs in order to contribute to global health.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 136 (2), 213-222, 2016-02-01

    公益社団法人 日本薬学会

参考文献 (2)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ